Epithalon, also known as Epitalon, Epithalamin, or Ala-Glu-Asp-Gly, is a synthetic tetrapeptide derived from the naturally occurring pineal gland peptide epithalamin. It consists of four amino acids: alanine, glutamic acid, aspartic acid, and glycine. Researchers synthesize Epithalon to mimic the effects of epithalamin, which is believed to play a role in regulating the body's aging processes. The compound is categorized under anti-aging and longevity research due to its potential effects on cellular aging and lifespan extension. Researchers have primarily investigated Epithalon in the context of its potential to modulate telomerase activity, which is an enzyme responsible for maintaining telomere length. Telomeres are protective caps on the ends of chromosomes that shorten with age, and their maintenance is associated with cellular longevity. Studies have also explored its effects on oxidative stress, immune function, and circadian rhythm regulation. The mechanism of action of Epithalon is thought to involve the upregulation of telomerase activity, thereby promoting telomere elongation and cellular longevity. It may also interact with various signaling pathways involved in stress response and cellular repair. However, the precise molecular targets and pathways remain under investigation. Pharmacokinetic data on Epithalon is limited, but researchers have noted its relatively short half-life, suggesting rapid metabolism and clearance from the body. Its stability and bioavailability may vary depending on the route of administration, with subcutaneous and intramuscular routes being more commonly studied. Current research on Epithalon is ongoing, with studies primarily in preclinical or early clinical stages. It is not approved as a medicinal product in many regions, and its use is largely confined to research settings. Regulatory standing varies by country, and it is often considered a research chemical rather than a therapeutic agent.